Recent Publications by Bial: |
Effect of questionnaire structure on recall of drug utilization in a population of university students.
BACKGROUND: Self-reported data are a common source of information about... | 11th November, 2009
| Department of Hygiene and Epidemiology, University of Porto Medical
| BMC Med Res Methodol. 2009 Jun 29;9:45.
DOI Direct Link |
Effect of eslicarbazepine acetate on the pharmacokinetics of digoxin in healthy subjects.
Eslicarbazepine acetate (ESL) is a new-generation voltage-gated sodium... | 31st October, 2009
| Department of Research and Development, BIAL - Portela & Co, SA, S Mamede
| Fundam Clin Pharmacol. 2009 Aug;23(4):509-14. Epub 2009 Jun 4.
DOI Direct Link |
Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
BACKGROUND: Specifically designed recombinant allergens with reduced IgE... | 31st October, 2009
| Bial-Aristegui, Research & Development Department, Bilbao, Spain.
| Clin Exp Allergy. 2009 Jul;39(7):1088-98. Epub 2009 Apr 21.
DOI Direct Link |
Species differences in pharmacokinetic and pharmacodynamic properties of nebicapone.
The present study was designed to characterize pharmacodynamic and... | 20th October, 2009
| Department of Research and Development, BIAL, 4745-457 S. Mamede do
| Biochem Pharmacol. 2009 Oct 15;78(8):1043-51. Epub 2009 Jun 6.
DOI Direct Link |
Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers.
This was a double-blind, randomised, placebo-controlled study to... | 28th August, 2009
| Department of Research and Development, BIAL-Portela & Co SA, S Mamede do
| Mol Nutr Food Res. 2009 May;53 Suppl 1:S7-15.
DOI Direct Link |
Effect of eslicarbazepine acetate on the pharmacokinetics of metformin in healthy subjects.
PURPOSE: Eslicarbazepine acetate (ESL) is a new voltage-gated sodium... | 3rd June, 2009
| Department of Research and Development, BIAL, S. Mamede do Coronado,
| Int J Clin Pharmacol Ther. 2009 Apr;47(4):255-61.
|
Recombinant hypoallergens for immunotherapy of Parietaria judaica pollen allergy.
Recombinant allergens are a promising alternative to crude allergen... | 8th April, 2009
| Bial-Aristegui, Research and Development Department, Alameda Urquijo, 27,
| Front Biosci. 2009 Jan 1;14:4606-17.
|
Adverse non-drug-related complaints by healthy volunteers in Phase I studies compared to the healthy general population.
OBJECTIVE: Some complaints that are reported as adverse drug reactions by... | 16th January, 2009
| Department of Research and Development, BIAL-Portela, SA, S. Mamede do
| Int J Clin Pharmacol Ther. 2008 Nov;46(11):574-83.
|
Effect of food on the pharmacokinetic profile of trans-resveratrol.
OBJECTIVE: It has been postulated that trans-resveratrol may act as an... | 16th January, 2009
| Department of Research and Development, BIAL, S. Mamede do Coronado,
| Int J Clin Pharmacol Ther. 2008 Nov;46(11):564-70.
|
Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
OBJECTIVE: Nebicapone is a new catechol-O-methyltransferase inhibitor. In... | 17th December, 2008
| Department of Research & Development, BIAL, S Mamede do Coronado,
| Eur J Clin Pharmacol. 2008 Oct;64(10):961-6. Epub 2008 Aug 6.
DOI Direct Link |
Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsy.
This study investigates the pharmacokinetics of eslicarbazepine acetate... | 4th November, 2008
| Department of Research and Development, BIAL, A Av. da Siderurgia
| J Clin Pharmacol. 2008 Aug;48(8):966-77. Epub 2008 May 28.
DOI Direct Link |
Personality characteristics of volunteers in Phase 1 studies and likelihood of reporting adverse events.
OBJECTIVE: To evaluate the personality characteristics of a group of... | 8th October, 2008
| Department of Research and Development, BIAL (Portela and Co., SA), S.
| Int J Clin Pharmacol Ther. 2008 Jul;46(7):340-8.
|
Efficient synthesis of 2-(trifluoromethyl)nicotinic acid derivatives from simple fluorinated precursors.
Novel routes to 2-trifluoromethyl-nicotinic acid derivatives have been... | 8th August, 2008
| BIAL-Portela and Ca, Trofa, Portugal.
| Org Lett. 2008 May 1;10(9):1835-7. Epub 2008 Apr 10.
DOI Direct Link |
Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate.
OBJECTIVE: Antiepileptic drugs are often used in patients with some degree... | 5th June, 2008
| Department of Research and Development, BIAL (Portela & Ca SA), S. Mamede
| Int J Clin Pharmacol Ther. 2008 Mar;46(3):119-30.
|
